Moneycontrol PRO
Black Friday Sale
Black Friday Sale
HomeNewsOpinionIs there a market upside to China’s COVID-19 lockdowns?

Is there a market upside to China’s COVID-19 lockdowns?

Policy makers have the ammunition to boost stocks as they counter an economic slowdown

April 13, 2022 / 08:40 IST
Foreign Ministry spokesperson Zhao Lijian on April 10 said China had “lodged solemn representations with the U.S." after the State Department advised Americans to reconsider traveling to China due to “arbitrary enforcement” of local laws and COVID-19 restrictions, particularly in Hong Kong, Jilin province and Shanghai. U.S. officials cited a risk of “parents and children being separated.” China was “strongly dissatisfied with and firmly opposed to the U.S. side’s groundless accusation against China’s epidemic response,” Zhao said. (Image: AP)
Bloomberg

The lockdown in Shanghai, accompanied by media accounts of food shortages and unreported deaths, are evoking painful recollections of January 2020 and the central city of Wuhan, where COVID-19 first broke out. For investors, the memory will also include the economic stimulus that China unleashed then to fight off a recession — as well as the bull market that ensued.

That may explain why China’s main stock indexes have not sunk below their mid-March low, even as the number of COVID-19 cases soared. Counterintuitively, since the initial outbreak in 2020, index returns were positively — not negatively — correlated with the number of cases, according to Goldman Sachs Group Inc.

By now, China has built a track record of containing COVID-19 outbreaks. As such, investors are looking through the short-term economic losses, and focusing instead on the policy goodies that Beijing is willing to hand out.

This time, the government may not be willing to shower the country with helicopter money. In 2020, a rapid expansion in credit caused the real estate market to overheat, driving home sales and prices to records. Then China spent much of 2021 trying to cool it down, argued Gavekal Research’s Wei He.

These days, regulations and the political backdrop — not COVID-19 outbreaks — have become influential trading themes. China can act on both those fronts to help its financial markets.

COVID-19 Vaccine

Frequently Asked Questions

View more
How does a vaccine work?

A vaccine works by mimicking a natural infection. A vaccine not only induces immune response to protect people from any future COVID-19 infection, but also helps quickly build herd immunity to put an end to the pandemic. Herd immunity occurs when a sufficient percentage of a population becomes immune to a disease, making the spread of disease from person to person unlikely. The good news is that SARS-CoV-2 virus has been fairly stable, which increases the viability of a vaccine.

How many types of vaccines are there?

There are broadly four types of vaccine — one, a vaccine based on the whole virus (this could be either inactivated, or an attenuated [weakened] virus vaccine); two, a non-replicating viral vector vaccine that uses a benign virus as vector that carries the antigen of SARS-CoV; three, nucleic-acid vaccines that have genetic material like DNA and RNA of antigens like spike protein given to a person, helping human cells decode genetic material and produce the vaccine; and four, protein subunit vaccine wherein the recombinant proteins of SARS-COV-2 along with an adjuvant (booster) is given as a vaccine.

What does it take to develop a vaccine of this kind?

Vaccine development is a long, complex process. Unlike drugs that are given to people with a diseased, vaccines are given to healthy people and also vulnerable sections such as children, pregnant women and the elderly. So rigorous tests are compulsory. History says that the fastest time it took to develop a vaccine is five years, but it usually takes double or sometimes triple that time.

View more
Show

Chinese stocks had a major slump last July when the government moved to investigate Didi Global Inc. over possible cyber-security issues just days after the ride-hailing giant’s $4.4 billion mega initial public offering in New York; the crackdown on big tech then stretched to more companies on issues such as data security and antitrust. In March, after Russia invaded Ukraine, stocks extended their losses, reflecting worries over secondary sanctions.

Bear Run | Regulatory and geopolitical risks have been driving China's stock market.

In recent days, we’ve started to see the first signs of the government unclenching its fists. On March 16, China’s top economic policy maker issued an unusual public statement seeking to “actively introduce policies that benefit markets.” This week, came the first batch of new video game licenses since July, ending a months-long hiatus that threatened the business models of Tencent Holdings Ltd., Netease Inc. and Bilibili Inc. Earlier this month, the government made a significant concession to the US Securities and Exchange Commission by revising rules that prevented US regulators from inspecting audit papers of New York-listed Chinese companies.

With an estimated 373 million people ensnared in some form of movement restrictions, economists are now talking about the risk of a recession. Goldman, for instance, sees China growing at only 4.5 percent this year, short of the government’s 5.5 percent target. Even Premier Li Keqiang has issued growth warnings to local government officials. When things are not going so great domestically, the hawkish branch of the political elite may just lose a little bit of their sway, be it in geopolitics or via tough regulations.

That’s because financial markets do matter. Ultimately, they determine the financing conditions for companies. The central bank could be cutting benchmark rates, but if stocks and corporate bonds are in a slump, how can businesses raise money to invest for the future?

For over a year now, investors were having a tough time, prompting some to question whether China has become ‘uninvestable’ due to the unpredictable policy making. The nation’s recent COVID-19 outbreaks change that view. After all, something’s got to give: China wants to save face and not be seen as ‘lying flat’ on COVID-19. A potential recession that triggers an urgent government response is not necessarily a bad thing for markets.

Shuli Ren is a Bloomberg Opinion columnist covering Asian markets. Views are personal, and do not represent the stand of this publication.
first published: Apr 13, 2022 08:40 am

Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!

Subscribe to Tech Newsletters

  • On Saturdays

    Find the best of Al News in one place, specially curated for you every weekend.

  • Daily-Weekdays

    Stay on top of the latest tech trends and biggest startup news.

Advisory Alert: It has come to our attention that certain individuals are representing themselves as affiliates of Moneycontrol and soliciting funds on the false promise of assured returns on their investments. We wish to reiterate that Moneycontrol does not solicit funds from investors and neither does it promise any assured returns. In case you are approached by anyone making such claims, please write to us at grievanceofficer@nw18.com or call on 02268882347